A phase II study of submandibular gland transfer prior to radiation for prevention of radiation-induced xerostomia in head-and-neck cancer (RTOG 0244)

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 2, 2012, Pages 437-442

  Jha, Naresh ^a   Harris, Jonathan ^b   Seikaly, Hadi ^a   Jacobs, John R ^c   McEwan, A J B ^a   Robbins, K Thomas ^d   Grecula, John ^e   Sharma, Anand K ^f   Ang, K Kian ^g  

^a UNIVERSITY OF ALBERTA   (Canada)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ST JOHN'S HOSPITAL   (United States)

^e THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; DISEASE FREE SURVIVAL; HEAD-AND-NECK CANCER; INTENSITY MODULATED RADIATION THERAPY; OROPHARYNX; PHASE II; RADIATION-INDUCED; REPRODUCIBILITIES; SALIVARY GLANDS; STUDY DESIGN; SUBMANDIBULAR GLANDS; SURGICAL TECHNIQUES; XEROSTOMIA;

CHEMOTHERAPY; SURGERY;

RADIOTHERAPY;

AMIFOSTINE; ANTINEOPLASTIC AGENT; PILOCARPINE;

ADULT; ARTICLE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NECK DISSECTION; ORAL SURGERY; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SUBMANDIBULAR SALIVARY GLAND TRANSFER; XEROSTOMIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RADIATION INJURIES; RECURRENCE; REPRODUCIBILITY OF RESULTS; SUBMANDIBULAR GLAND; XEROSTOMIA;

EID: 84865616451     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.02.034     Document Type: Article

References (21)

1. J.D. Chencharick, and K.L. Mossman Nutritional consequences of radiotherapy of head and neck cancer Cancer 51 1983 811 815
2. D.M. Brizel, T.H. Wasserman, and M. Henke Phase III randomized trial of amifostine as a radioprotector in head and neck cancer J Clin Oncol 18 19 2000 3339 3345
3. S. Jabbari, H.M. Kim, and M. Feng Matched case control study of quality of life and xerostomia after intensity modulated radiotherapy or standard radiotherapy for head and neck cancer: Initial Report Int J Radiat Oncol Biol Phys 63 3 2005 725 731
4. F.M. Fang, W.L. Tsai, and H.C. Chen Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques Cancer 109 2 2007 313 321
5. J.W. Rieke, M.D. Hafermann, and J.T. Johnson Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials Int J Radiat Oncol Biol Phys 31 3 1995 661 669
6. C. Scarantino, F. LeVeque, and R.S. Swann Effect of pilocarpine during radiation therapy: results of RTOG 97-09 a phase III randomized study in head and neck cancer patients J Support Oncol 4 5 2006 252 258
7. N. Jha, H. Seikaly, and T. McGaw Submandibular salivary gland transfer prevents radiation induced xerostomia Int J Radiat Oncol Biol Phys 46 1 2000 7 11
8. H. Seikaly, N. Jha, and T. McGaw Submandibular gland transfer prevents postoperative radiation induced xerostomia Laryngoscope 111 2 2001 347 352
9. H. Seikaly, N. Jha, and P. Barnaby Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia Arch Otolaryngol Head Neck Surg 130 8 2004 956 961
10. K.A. Pathak, R.L. Bhalavat, and R.C. Mistry Upfront submandibular salivary gland transfer in pharyngeal cancers Oral Oncol 40 9 2004 960 963
11. X.K. Liu, Y. Su, and N. Jha Submandibular salivary gland transfer for the prevention of radiation-induced xerostomia in patients with nasopharyngeal carcinoma: 5-year outcomes Head Neck 33 3 2011 389 395
12. D.I. Rosenthal, M.S. Chambers, and R.S. Weber A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing Semin Oncol 31 suppl 18 2004 S25 S28
13. K. Saarilahti, M. Kouri, and J. Collan Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer [Erratum] Radiother Oncol 80 1 2006 107 108
14. A. Eisbruch, J. Harris, and A.S. Garden Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22) Int J Radiat Oncol Biol Phys 76 5 2010 1333 1338
15. J. Buentzel, O. Micke, and I.A. Adamietz Intravenous amifostine during chemoradiotherapy for head and neck cancer: a randomized placebo-ontrolled phase III study Int J Radiat Oncol Biol Phys 64 3 2006 684 691
16. S. Nangia, K.S. Chufal, and A. Tyagi Selective nodal irradiation for head and neck cancer using intensity modulated radiotherapy: application of RTOG consensus guidelines in routine clinical practice Int J Radiat Oncol Biol Phys 76 1 2010 146 153
17. M.R. Vergeer, P.A.H. Doornaert, and D.H.F. Rietveld Intensity modulated radiotherapy reduces radiation induced morbidity and improves health related quality of life: results of a nonrandomized prospective study using a standardized follow up program Int Radiat Oncol Biol Phys 74 1 2009 1 8
18. T.H. Wasserman, D. Brizel, and M. Henke Influence of intravenous amifostine on xerostomia, tumor control and survival after radiotherapy for head and neck cancer: 2 year follow up of a prospective, randomized, phase III trial Int J Radiat Oncol Biol Phys 63 4 2005 985 990
19. N. Lee, P. Xia, and J.M. Quivey Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience Int J Radiat Oncol Biol Phys 53 1 2002 12 22
20. N. Jha, H. Seikaly, and D. Williams Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia Head Neck 31 2 2009 234 243
21. DM Brizel, TH Wasserman, and M Henke Phase III randomized trial of amifostine as a radioprotector in head and neck cancer J Clin Oncol 18 19 2000 3339 3345